Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients

Auli Verkkoniemi-Ahola, Päivi Hartikainen, Katja Hassi, Hanna Kuusisto, Sanni Lahdenperä, Juha Mehtälä, Matias Viitala, Tero Ylisaukko-oja, Merja Soilu-Hänninen

Research output: Contribution to journalArticleScientificpeer-review

1 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients'. Together they form a unique fingerprint.

Keyphrases

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology